Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Cancer & Clinical Oncology|November 1, 1989
Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocolsV Combaret, Q Wang, M C Favrot, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK)C Coze, V Combaret, I Philip, et al.
Annales De Cardiologie Et D'Angeiologie|September 1, 1994
[Thromboses of heart valve prostheses: predisposing and prognostic factors based on a study of 41 patients]R Mustapha, I Philip, G Bohm, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1986
Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience)T Philip, P Biron, I Philip, et al.
Bone Marrow Transplantation|November 1, 1992
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 casesC Dumontet, P Biron, E Bouffet, et al.
Annales De Chirurgie|January 1, 1994
[Thrombosis of heart valve prostheses: favourable and prognostic factors based on a study of 41 patients]R Mustapha, I Philip, G Bohm, et al.
British Journal of Haematology|August 1, 1985
Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphomaT Philip, P Biron, D Maraninchi, et al.
The European Respiratory Journal|October 21, 2009
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevanceC Quesnel, L Nardelli, P Piednoir, et al.
Medical and Pediatric Oncology|January 1, 1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II studyC R Pinkerton, T Philip, P Biron, et al.
British Journal of Cancer|March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapyI Ray-Coquard, C Borg, Th Bachelot, et al.
Pageof 12